医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Jamieson Wellness Inc. Secures New Product Licences in China

2019年06月05日 PM08:00
このエントリーをはてなブックマークに追加


 

TORONTO

Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX:JWEL), Canada’s number one manufacturer and marketer of branded vitamins, minerals and supplements, announced today that the Company has received three additional product licences from the FDA in China. These licences add to the Company’s six existing licences, allowing the products to be sold in the Chinese domestic retail and e-commerce markets.

“Tapping the domestic market in China is an exciting opportunity for us, and a key part of our international growth platform,” said Mark Hornick, President and CEO of Jamieson Wellness. “Our goal is to have 15-20 products available in the domestic market in China by the end of 2019, and these new licences keep us nicely on-track to meet that expectation.”

The Jamieson brand is known by Chinese consumers, having been available through various channels in the country for nearly 20 years. To date, the Company has been working with its distributor to sell products through cross-border e-commerce, doubling shipments year-over-year in 2018 to support its rapid growth. Since the beginning of 2019, Jamieson business in this channel continues to grow and exceed Company expectations.

In anticipation of a launch into the domestic channel, the Company established operations in Shanghai in 2018, and continues to build new and existing relationships with domestic retail and e-commerce partners. Strong demand has resulted in purchase orders for all domestic licensed products, including the three newly licensed products. Initial orders are expected to begin shipping in Q3 2019.

About Jamieson Wellness

Jamieson Wellness is dedicated to improving the world’s health and wellness with its portfolio of innovative natural health brands. Established in 1922, Jamieson is the Company’s heritage brand and Canada’s #1 consumer health brand. Jamieson Wellness manufactures and markets sports nutrition products and specialty supplements under its Progressive, Precision and Iron Vegan brands. The Company also markets products by Lorna Vanderhaeghe Health Solutions (LVHS), the #1 women’s natural health focused brand in Canada. In 2019, Jamieson Wellness was named as one of the top ten most reputable Canadian companies by the Reputation Institute. For more information please visit jamiesonwellness.com.

Forward-Looking Information

This press release may contain forward-looking information within the meaning of applicable securities legislation. Words such as “expect,” “anticipate,” “intend,” “attempt,” “may,” “plan,” “will,” “can,” “believe,” “seek,” and variations of such words and similar expressions are intended to identify such forward-looking information. This information reflects the Company’s current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond the Company’s control, that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. This information is based on the Company’s reasonable assumptions and beliefs in light of the information currently available to it and the statements are made as of the date of this press release. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law or regulatory authority. Readers are cautioned not to place undue reliance on this forward-looking information.

Source: Jamieson Wellness Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190605005253/en/

CONTACT

Jamieson Wellness
Ruth Winker
416-705-5437
rwinker@jamiesonlabs.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • LetsGetChecked、FDAのEUA承認を受けた在宅型コロナウイルス(COVID-19)検査用シュア・トラック・テストを発表
  • 欧盟委员会同意武田无需履行剥离夏尔后续化合物SHP647的承诺
  • Celltrion Announces Positive Pre-clinical Results for COVID- 19 Antiviral Antibody Treatment, Showing Improvement in Recovery Time
  • Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer
  • ENHERTU® Significantly Improved Tumor Response Rate and Overall Survival in HER2 Positive Metastatic Gastric Cancer in Pivotal Phase 2 DESTINY-Gastric01 Trial